<DOC>
	<DOC>NCT01974323</DOC>
	<brief_summary>This study will assess the safety and efficacy of dapsone gel versus vehicle control in patients with acne vulgaris.</brief_summary>
	<brief_title>Safety and Efficacy Study of Dapsone Gel in Patients With Acne Vulgaris</brief_title>
	<detailed_description>This is a multicenter, double-blind, randomized, parallel-group, vehicle-controlled study to assess the safety and efficacy of dapsone 7.5% gel versus vehicle administered topically once daily for 12 weeks in patients with acne vulgaris.</detailed_description>
	<mesh_term>Acne Vulgaris</mesh_term>
	<mesh_term>Dapsone</mesh_term>
	<criteria>Diagnosis of acne vulgaris Willing to avoid excessive or prolonged exposure to ultraviolet light (eg, sunlight, tanning beds) throughout the study Severe cystic acne, acne conglobata, acne fulminans, or secondary acne Use of phototherapy devices (eg, ClearLight™), energybased devices, adhesive cleansing strips (eg, Pond's®, Biore®), or cosmetic procedures (eg, facials, peeling, comedo extraction) in the past week Use of antiinflammatory medications, salicylic acid; corticosteroids, antibiotics, antibacterials (including benzoyl peroxidecontaining products [eg, benzamycin]), retinoids; other topical acne treatments (eg, photodynamic therapy, medicated soaps such as those containing benzoyl peroxide, salicylic acid, sulfur, or sodium sulfacetamide) in the past 2 weeks Use of birth control pills strictly for acne control</criteria>
	<gender>All</gender>
	<minimum_age>12 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>